CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma
Ayumi Yoshizaki(University of Tokyo Hospital), Shinichi Sato(University of Tokyo Hospital), Kazuhiro Komura(Kanazawa University), Thomas F. Tedder(Duke Medical Center), Minoru Hasegawa(University of Fukui), Yohei Iwata(Fujita Health University), Eiji Muroi(Nagasaki University), Toshihide Hara(Nagasaki University), Fumihide Ogawa(Nagasaki University), Motoi Takenaka(Washington University in St. Louis), Kazuhiro Shimizu(Nagasaki University), Manabu Fujimoto(Osaka Gakuin University)
Cited by 204
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
|The Journal of Experimental Medicine|2004|631